APO Research
Talk to an analyst

APO RESEARCH · REPORT

EGFR-TKI

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global EGFR-TKI Industry Growth and Trends Forecast to 2032

27 December 2025118 pages

Choose your research edition.

Industry ResearchEGFR-TKI Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal EGFR-TKI Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal EGFR-TKI Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal EGFR-TKI Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal EGFR-TKI Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global EGFR-TKI market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for EGFR-TKI is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for EGFR-TKI is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for EGFR-TKI is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of EGFR-TKI include ArriVent Biopharma, AstraZeneca, Beacon Pharma, Boehringer Ingelheim Pharmaceuticals, Cipla, Drug International, Glenmark Pharmaceuticals, Hanmi Pharmaceutical and Johnson & Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global EGFR-TKI market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The EGFR-TKI market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global EGFR-TKI market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to EGFR-TKI.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global EGFR-TKI market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

EGFR-TKI Market by Company

ArriVent Biopharma

AstraZeneca

Beacon Pharma

Boehringer Ingelheim Pharmaceuticals

Cipla

Drug International

Glenmark Pharmaceuticals

Hanmi Pharmaceutical

Johnson & Johnson

Mylan

Pfizer

Roche

Teva

Yuhan Corporation

Betta Pharma

Chengdu Brilliant Pharmaceuticals

Hansoh Pharma

Shanghai Allist Pharmaceuticals

Wanbang Biopharmaceuticals

EGFR-TKI Segment by Type

Afatinib

Aumolertinib

Icotinib

Osimertinib

Dacomitinib

Erlotinib

Furmonertinib

Gefitinib

Lazertinib

Other

EGFR-TKI Segment by Application

Segment by Application

Hospital and Clinic

Retail Pharmacies

Other

EGFR-TKI Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global EGFR-TKI market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of EGFR-TKI and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of EGFR-TKI.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of EGFR-TKI manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of EGFR-TKI in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Afatinib Table 2. Major Company of Aumolertinib Table 3. Major Company of Icotinib Table 4. Major Company of Osimertinib Table 5. Major Company of Dacomitinib Table 6. Major Company of Erlotinib Table 7. Major Company of Furmonertinib Table 8. Major Company of Gefitinib Table 9. Major Company of Lazertinib Table 10. Major Company of Other Table 11. Global EGFR-TKI Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 12. Global EGFR-TKI Sales by Type (2021-2026) & (K Units) Table 13. Global EGFR-TKI Sales Market Share in Volume by Type (2021-2026) Table 14. Global EGFR-TKI Sales by Type (2021-2026) & (US$ Million) Table 15. Global EGFR-TKI Sales Market Share in Value by Type (2021-2026) Table 16. Global EGFR-TKI Price by Type (2021-2026) & (US$/Unit) Table 17. Global EGFR-TKI Sales by Type (2027-2032) & (K Units) Table 18. Global EGFR-TKI Sales Market Share in Volume by Type (2027-2032) Table 19. Global EGFR-TKI Sales by Type (2027-2032) & (US$ Million) Table 20. Global EGFR-TKI Sales Market Share in Value by Type (2027-2032) Table 21. Global EGFR-TKI Price by Type (2027-2032) & (US$/Unit) Table 22. North America EGFR-TKI Sales by Type (2021-2026) & (K Units) Table 23. North America EGFR-TKI Sales by Type (2021-2026) & (US$ Million) Table 24. Europe EGFR-TKI Sales by Type (2021-2026) & (K Units) Table 25. Europe EGFR-TKI Sales by Type (2021-2026) & (US$ Million) Table 26. Asia-Pacific EGFR-TKI Sales by Type (2021-2026) & (K Units) Table 27. Asia-Pacific EGFR-TKI Sales by Type (2021-2026) & (US$ Million) Table 28. Latin America EGFR-TKI Sales by Type (2021-2026) & (K Units) Table 29. Latin America EGFR-TKI Sales by Type (2021-2026) & (US$ Million) Table 30. Middle East and Africa EGFR-TKI Sales by Type (2021-2026) & (K Units) Table 31. Middle East and Africa EGFR-TKI Sales by Type (2021-2026) & (US$ Million) Table 32. EGFR-TKI Industry Trends Table 33. EGFR-TKI Industry Drivers Table 34. EGFR-TKI Industry Opportunities and Challenges Table 35. EGFR-TKI Industry Restraints Table 36. Global EGFR-TKI Sales Revenue by Company (US$ Million) & (2021-2026) Table 37. Global EGFR-TKI Revenue Market Share by Company (2021-2026) Table 38. Global EGFR-TKI Sales by Company (2021-2026) & (K Units) Table 39. Global EGFR-TKI Sales Share by Company (2021-2026) Table 40. Global EGFR-TKI Market Price by Company (2021-2026) & (US$/Unit) Table 41. Global EGFR-TKI Industry Company Ranking, 2024 VS 2025 VS 2026 Table 42. Global EGFR-TKI Major Company Production Sites and Headquarters Table 43. Global EGFR-TKI Company, Product Type & Application Table 44. Global EGFR-TKI Company Establishment Date Table 45. Global Company Market Concentration Ratio (CR5 and HHI) Table 46. Global EGFR-TKI by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 47. Global EGFR-TKI Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 48. Global EGFR-TKI Sales by Region (2021-2026) & (K Units) Table 49. Global EGFR-TKI Sales Market Share in Volume by Region (2021-2026) Table 50. Global EGFR-TKI Sales by Region (2021-2026) & (US$ Million) Table 51. Global EGFR-TKI Sales Market Share in Value by Region (2021-2026) Table 52. Global EGFR-TKI Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 53. Global EGFR-TKI Sales by Region (2027-2032) & (K Units) Table 54. Global EGFR-TKI Sales Market Share in Volume by Region (2027-2032) Table 55. Global EGFR-TKI Sales by Region (2027-2032) & (US$ Million) Table 56. Global EGFR-TKI Sales Market Share in Value by Region (2027-2032) Table 57. Global EGFR-TKI Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 58. Global EGFR-TKI Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 59. Global EGFR-TKI Sales by Application (2021-2026) & (K Units) Table 60. Global EGFR-TKI Sales Market Share in Volume by Application (2021-2026) Table 61. Global EGFR-TKI Sales by Application (2021-2026) & (US$ Million) Table 62. Global EGFR-TKI Sales Market Share in Value by Application (2021-2026) Table 63. Global EGFR-TKI Price by Application (2021-2026) & (US$/Unit) Table 64. Global EGFR-TKI Sales by Application (2027-2032) & (K Units) Table 65. Global EGFR-TKI Sales Market Share in Volume by Application (2027-2032) Table 66. Global EGFR-TKI Sales by Application (2027-2032) & (US$ Million) Table 67. Global EGFR-TKI Sales Market Share in Value by Application (2027-2032) Table 68. Global EGFR-TKI Price by Application (2027-2032) & (US$/Unit) Table 69. North America EGFR-TKI Sales by Application (2021-2026) & (K Units) Table 70. North America EGFR-TKI Sales by Application (2021-2026) & (US$ Million) Table 71. Europe EGFR-TKI Sales by Application (2021-2026) & (K Units) Table 72. Europe EGFR-TKI Sales by Application (2021-2026) & (US$ Million) Table 73. Asia-Pacific EGFR-TKI Sales by Application (2021-2026) & (K Units) Table 74. Asia-Pacific EGFR-TKI Sales by Application (2021-2026) & (US$ Million) Table 75. Latin America EGFR-TKI Sales by Application (2021-2026) & (K Units) Table 76. Latin America EGFR-TKI Sales by Application (2021-2026) & (US$ Million) Table 77. Middle East and Africa EGFR-TKI Sales by Application (2021-2026) & (K Units) Table 78. Middle East and Africa EGFR-TKI Sales by Application (2021-2026) & (US$ Million) Table 79. ArriVent Biopharma Company Information Table 80. ArriVent Biopharma Business Overview Table 81. ArriVent Biopharma EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. ArriVent Biopharma EGFR-TKI Product Portfolio Table 83. ArriVent Biopharma Recent Development Table 84. AstraZeneca Company Information Table 85. AstraZeneca Business Overview Table 86. AstraZeneca EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. AstraZeneca EGFR-TKI Product Portfolio Table 88. AstraZeneca Recent Development Table 89. Beacon Pharma Company Information Table 90. Beacon Pharma Business Overview Table 91. Beacon Pharma EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Beacon Pharma EGFR-TKI Product Portfolio Table 93. Beacon Pharma Recent Development Table 94. Boehringer Ingelheim Pharmaceuticals Company Information Table 95. Boehringer Ingelheim Pharmaceuticals Business Overview Table 96. Boehringer Ingelheim Pharmaceuticals EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Boehringer Ingelheim Pharmaceuticals EGFR-TKI Product Portfolio Table 98. Boehringer Ingelheim Pharmaceuticals Recent Development Table 99. Cipla Company Information Table 100. Cipla Business Overview Table 101. Cipla EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Cipla EGFR-TKI Product Portfolio Table 103. Cipla Recent Development Table 104. Drug International Company Information Table 105. Drug International Business Overview Table 106. Drug International EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Drug International EGFR-TKI Product Portfolio Table 108. Drug International Recent Development Table 109. Glenmark Pharmaceuticals Company Information Table 110. Glenmark Pharmaceuticals Business Overview Table 111. Glenmark Pharmaceuticals EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Glenmark Pharmaceuticals EGFR-TKI Product Portfolio Table 113. Glenmark Pharmaceuticals Recent Development Table 114. Hanmi Pharmaceutical Company Information Table 115. Hanmi Pharmaceutical Business Overview Table 116. Hanmi Pharmaceutical EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Hanmi Pharmaceutical EGFR-TKI Product Portfolio Table 118. Hanmi Pharmaceutical Recent Development Table 119. Johnson & Johnson Company Information Table 120. Johnson & Johnson Business Overview Table 121. Johnson & Johnson EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Johnson & Johnson EGFR-TKI Product Portfolio Table 123. Johnson & Johnson Recent Development Table 124. Mylan Company Information Table 125. Mylan Business Overview Table 126. Mylan EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Mylan EGFR-TKI Product Portfolio Table 128. Mylan Recent Development Table 129. Pfizer Company Information Table 130. Pfizer Business Overview Table 131. Pfizer EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Pfizer EGFR-TKI Product Portfolio Table 133. Pfizer Recent Development Table 134. Roche Company Information Table 135. Roche Business Overview Table 136. Roche EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Roche EGFR-TKI Product Portfolio Table 138. Roche Recent Development Table 139. Teva Company Information Table 140. Teva Business Overview Table 141. Teva EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Teva EGFR-TKI Product Portfolio Table 143. Teva Recent Development Table 144. Yuhan Corporation Company Information Table 145. Yuhan Corporation Business Overview Table 146. Yuhan Corporation EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Yuhan Corporation EGFR-TKI Product Portfolio Table 148. Yuhan Corporation Recent Development Table 149. Betta Pharma Company Information Table 150. Betta Pharma Business Overview Table 151. Betta Pharma EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 152. Betta Pharma EGFR-TKI Product Portfolio Table 153. Betta Pharma Recent Development Table 154. Chengdu Brilliant Pharmaceuticals Company Information Table 155. Chengdu Brilliant Pharmaceuticals Business Overview Table 156. Chengdu Brilliant Pharmaceuticals EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 157. Chengdu Brilliant Pharmaceuticals EGFR-TKI Product Portfolio Table 158. Chengdu Brilliant Pharmaceuticals Recent Development Table 159. Hansoh Pharma Company Information Table 160. Hansoh Pharma Business Overview Table 161. Hansoh Pharma EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 162. Hansoh Pharma EGFR-TKI Product Portfolio Table 163. Hansoh Pharma Recent Development Table 164. Shanghai Allist Pharmaceuticals Company Information Table 165. Shanghai Allist Pharmaceuticals Business Overview Table 166. Shanghai Allist Pharmaceuticals EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 167. Shanghai Allist Pharmaceuticals EGFR-TKI Product Portfolio Table 168. Shanghai Allist Pharmaceuticals Recent Development Table 169. Wanbang Biopharmaceuticals Company Information Table 170. Wanbang Biopharmaceuticals Business Overview Table 171. Wanbang Biopharmaceuticals EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 172. Wanbang Biopharmaceuticals EGFR-TKI Product Portfolio Table 173. Wanbang Biopharmaceuticals Recent Development Table 174. North America EGFR-TKI Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 175. North America EGFR-TKI Sales by Country (2021-2026) & (K Units) Table 176. North America EGFR-TKI Sales Market Share by Country (2021-2026) Table 177. North America EGFR-TKI Sales Forecast by Country (2027-2032) & (K Units) Table 178. North America EGFR-TKI Sales Market Share Forecast by Country (2027-2032) Table 179. North America EGFR-TKI Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 180. North America EGFR-TKI Market Size by Country (2021-2026) & (US$ Million) Table 181. North America EGFR-TKI Market Share by Country (2021-2026) Table 182. North America EGFR-TKI Market Size Forecast by Country (2027-2032) & (US$ Million) Table 183. North America EGFR-TKI Market Share Forecast by Country (2027-2032) Table 184. Europe EGFR-TKI Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 185. Europe EGFR-TKI Sales by Country (2021-2026) & (K Units) Table 186. Europe EGFR-TKI Sales Market Share by Country (2021-2026) Table 187. Europe EGFR-TKI Sales Forecast by Country (2027-2032) & (K Units) Table 188. Europe EGFR-TKI Sales Market Share Forecast by Country (2027-2032) Table 189. Europe EGFR-TKI Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 190. Europe EGFR-TKI Market Size by Country (2021-2026) & (US$ Million) Table 191. Europe EGFR-TKI Market Share by Country (2021-2026) Table 192. Europe EGFR-TKI Market Size Forecast by Country (2027-2032) & (US$ Million) Table 193. Europe EGFR-TKI Market Share Forecast by Country (2027-2032) Table 194. Asia-Pacific EGFR-TKI Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 195. Asia-Pacific EGFR-TKI Sales by Country (2021-2026) & (K Units) Table 196. Asia-Pacific EGFR-TKI Sales Market Share by Country (2021-2026) Table 197. Asia-Pacific EGFR-TKI Sales Forecast by Country (2027-2032) & (K Units) Table 198. Asia-Pacific EGFR-TKI Sales Market Share Forecast by Country (2027-2032) Table 199. Asia-Pacific EGFR-TKI Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 200. Asia-Pacific EGFR-TKI Market Size by Country (2021-2026) & (US$ Million) Table 201. Asia-Pacific EGFR-TKI Market Share by Country (2021-2026) Table 202. Asia-Pacific EGFR-TKI Market Size Forecast by Country (2027-2032) & (US$ Million) Table 203. Asia-Pacific EGFR-TKI Market Share Forecast by Country (2027-2032) Table 204. Latin America EGFR-TKI Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 205. Latin America EGFR-TKI Sales by Country (2021-2026) & (K Units) Table 206. Latin America EGFR-TKI Sales Market Share by Country (2021-2026) Table 207. Latin America EGFR-TKI Sales Forecast by Country (2027-2032) & (K Units) Table 208. Latin America EGFR-TKI Sales Market Share Forecast by Country (2027-2032) Table 209. Latin America EGFR-TKI Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 210. Latin America EGFR-TKI Market Size by Country (2021-2026) & (US$ Million) Table 211. Latin America EGFR-TKI Market Share by Country (2021-2026) Table 212. Latin America EGFR-TKI Market Size Forecast by Country (2027-2032) & (US$ Million) Table 213. Latin America EGFR-TKI Market Share Forecast by Country (2027-2032) Table 214. Middle East and Africa EGFR-TKI Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 215. Middle East and Africa EGFR-TKI Sales by Country (2021-2026) & (K Units) Table 216. Middle East and Africa EGFR-TKI Sales Market Share by Country (2021-2026) Table 217. Middle East and Africa EGFR-TKI Sales Forecast by Country (2027-2032) & (K Units) Table 218. Middle East and Africa EGFR-TKI Sales Market Share Forecast by Country (2027-2032) Table 219. Middle East and Africa EGFR-TKI Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 220. Middle East and Africa EGFR-TKI Market Size by Country (2021-2026) & (US$ Million) Table 221. Middle East and Africa EGFR-TKI Market Share by Country (2021-2026) Table 222. Middle East and Africa EGFR-TKI Market Size Forecast by Country (2027-2032) & (US$ Million) Table 223. Middle East and Africa EGFR-TKI Market Share Forecast by Country (2027-2032) Table 224. Key Raw Materials Table 225. Raw Materials Key Suppliers Table 226. EGFR-TKI Distributors List Table 227. EGFR-TKI Customers List Table 228. Research Programs/Design for This Report Table 229. Authors List of This Report Table 230. Secondary Sources Table 231. Primary Sources List of Figures Figure 1. EGFR-TKI Image Figure 2. Global EGFR-TKI Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global EGFR-TKI Market Size (2021-2032) & (US$ Million) Figure 4. Global EGFR-TKI Sales (2021-2032) & (K Units) Figure 5. Afatinib Image Figure 6. Global Afatinib Sales YoY Growth (2021-2032) & (K Units) Figure 7. Aumolertinib Image Figure 8. Global Aumolertinib Sales YoY Growth (2021-2032) & (K Units) Figure 9. Icotinib Image Figure 10. Global Icotinib Sales YoY Growth (2021-2032) & (K Units) Figure 11. Osimertinib Image Figure 12. Global Osimertinib Sales YoY Growth (2021-2032) & (K Units) Figure 13. Dacomitinib Image Figure 14. Global Dacomitinib Sales YoY Growth (2021-2032) & (K Units) Figure 15. Erlotinib Image Figure 16. Global Erlotinib Sales YoY Growth (2021-2032) & (K Units) Figure 17. Furmonertinib Image Figure 18. Global Furmonertinib Sales YoY Growth (2021-2032) & (K Units) Figure 19. Gefitinib Image Figure 20. Global Gefitinib Sales YoY Growth (2021-2032) & (K Units) Figure 21. Lazertinib Image Figure 22. Global Lazertinib Sales YoY Growth (2021-2032) & (K Units) Figure 23. Other Image Figure 24. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 25. Global EGFR-TKI Market Size Overview by Type (2021-2032) & (US$ Million) Figure 26. Global EGFR-TKI Market Share by Type 2025 VS 2032 Figure 27. North America EGFR-TKI Sales Market Share in Volume by Type in 2025 Figure 28. North America EGFR-TKI Sales Market Share in Value by Type in 2025 Figure 29. Europe EGFR-TKI Sales Market Share in Volume by Type in 2025 Figure 30. Europe EGFR-TKI Sales Market Share in Value by Type in 2025 Figure 31. Asia-Pacific EGFR-TKI Sales Market Share in Volume by Type in 2025 Figure 32. Asia-Pacific EGFR-TKI Sales Market Share in Value by Type in 2025 Figure 33. Latin America EGFR-TKI Sales Market Share in Volume by Type in 2025 Figure 34. Latin America EGFR-TKI Sales Market Share in Value by Type in 2025 Figure 35. Middle East and Africa EGFR-TKI Sales Market Share in Volume by Type in 2025 Figure 36. Middle East and Africa EGFR-TKI Sales Market Share in Value by Type in 2025 Figure 37. Global Top 5 and 10 EGFR-TKI Players Market Share by Revenue in 2025 Figure 38. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 39. Segment by Application Image Figure 40. Global Segment by Application Sales YoY Growth (2021-2032) & (K Units) Figure 41. Hospital and Clinic Image Figure 42. Global Hospital and Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 43. Retail Pharmacies Image Figure 44. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 45. Other Image Figure 46. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 47. Global EGFR-TKI Market Size Overview by Application (2021-2032) & (US$ Million) Figure 48. Global EGFR-TKI Market Share by Application 2025 VS 2032 Figure 49. North America EGFR-TKI Sales Market Share in Volume by Application in 2025 Figure 50. North America EGFR-TKI Sales Market Share in Value by Application in 2025 Figure 51. Europe EGFR-TKI Sales Market Share in Volume by Application in 2025 Figure 52. Europe EGFR-TKI Sales Market Share in Value by Application in 2025 Figure 53. Asia-Pacific EGFR-TKI Sales Market Share in Volume by Application in 2025 Figure 54. Asia-Pacific EGFR-TKI Sales Market Share in Value by Application in 2025 Figure 55. Latin America EGFR-TKI Sales Market Share in Volume by Application in 2025 Figure 56. Latin America EGFR-TKI Sales Market Share in Value by Application in 2025 Figure 57. Middle East and Africa EGFR-TKI Sales Market Share in Volume by Application in 2025 Figure 58. Middle East and Africa EGFR-TKI Sales Market Share in Value by Application in 2025 Figure 59. North America EGFR-TKI Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. North America EGFR-TKI Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. North America EGFR-TKI Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. North America EGFR-TKI Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe EGFR-TKI Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Europe EGFR-TKI Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Europe EGFR-TKI Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Europe EGFR-TKI Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Asia-Pacific EGFR-TKI Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 68. Asia-Pacific EGFR-TKI Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Asia-Pacific EGFR-TKI Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Asia-Pacific EGFR-TKI Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Latin America EGFR-TKI Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 72. Latin America EGFR-TKI Sales Share by Country: 2021 VS 2025 VS 2032 Figure 73. Latin America EGFR-TKI Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 74. Latin America EGFR-TKI Market Share by Country: 2021 VS 2025 VS 2032 Figure 75. Middle East and Africa EGFR-TKI Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 76. Middle East and Africa EGFR-TKI Sales Share by Country: 2021 VS 2025 VS 2032 Figure 77. Middle East and Africa EGFR-TKI Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 78. Middle East and Africa EGFR-TKI Market Share by Country: 2021 VS 2025 VS 2032 Figure 79. EGFR-TKI Value Chain Figure 80. Key Raw Materials Price Figure 81. Manufacturing Cost Structure Figure 82. EGFR-TKI Production Mode & Process Figure 83. Direct Comparison with Distribution Share Figure 84. Distributors Profiles Figure 85. Years Considered Figure 86. Research Process Figure 87. Key Executives Interviewed

Scope & coverage.

Types
  • Afatinib
  • Aumolertinib
  • Icotinib
  • Osimertinib
  • Dacomitinib
  • Erlotinib
  • Furmonertinib
  • Gefitinib
  • Lazertinib
  • Other
Applications
  • Segment by Application
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Companies covered
  • ArriVent Biopharma
  • AstraZeneca
  • Beacon Pharma
  • Boehringer Ingelheim Pharmaceuticals
  • Cipla
  • Drug International
  • Glenmark Pharmaceuticals
  • Hanmi Pharmaceutical
  • Johnson & Johnson
  • Mylan
  • Pfizer
  • Roche
  • Teva
  • Yuhan Corporation
  • Betta Pharma
  • Chengdu Brilliant Pharmaceuticals
  • Hansoh Pharma
  • Shanghai Allist Pharmaceuticals
  • Wanbang Biopharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global EGFR-TKI Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global EGFR-TKI Sales Estimates and Forecasts (2021-2032)
  5. 1.3 EGFR-TKI Market by Type
  6. 1.3.1 Afatinib
  7. 1.3.2 Aumolertinib
  8. 1.3.3 Icotinib
  9. 1.3.4 Osimertinib
  10. 1.3.5 Dacomitinib
  11. 1.3.6 Erlotinib
  12. 1.3.7 Furmonertinib
  13. 1.3.8 Gefitinib
  14. 1.3.9 Lazertinib
  15. 1.3.10 Other
  16. 1.4 Global EGFR-TKI Market Size by Type
  17. 1.4.1 Global EGFR-TKI Market Size Overview by Type (2021-2032)
  18. 1.4.2 Global EGFR-TKI Historic Market Size Review by Type (2021-2026)
  19. 1.4.3 Global EGFR-TKI Forecasted Market Size by Type (2027-2032)
  20. 1.5 Key Regions Market Size by Type
  21. 1.5.1 North America EGFR-TKI Sales Breakdown by Type (2021-2026)
  22. 1.5.2 Europe EGFR-TKI Sales Breakdown by Type (2021-2026)
  23. 1.5.3 Asia-Pacific EGFR-TKI Sales Breakdown by Type (2021-2026)
  24. 1.5.4 South America EGFR-TKI Sales Breakdown by Type (2021-2026)
  25. 1.5.5 Middle East and Africa EGFR-TKI Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 EGFR-TKI Industry Trends
  2. 2.2 EGFR-TKI Industry Drivers
  3. 2.3 EGFR-TKI Industry Opportunities and Challenges
  4. 2.4 EGFR-TKI Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by EGFR-TKI Revenue (2021-2026)
  2. 3.2 Global Top Players by EGFR-TKI Sales (2021-2026)
  3. 3.3 Global Top Players by EGFR-TKI Price (2021-2026)
  4. 3.4 Global EGFR-TKI Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global EGFR-TKI Major Company Production Sites & Headquarters
  6. 3.6 Global EGFR-TKI Company, Product Type & Application
  7. 3.7 Global EGFR-TKI Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global EGFR-TKI Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 EGFR-TKI Players Market Share by Revenue in 2025
  11. 3.8.3 2025 EGFR-TKI Tier 1, Tier 2, and Tier 3
4 EGFR-TKI Regional Status and Outlook
  1. 4.1 Global EGFR-TKI Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global EGFR-TKI Historic Market Size by Region
  3. 4.2.1 Global EGFR-TKI Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global EGFR-TKI Sales in Value by Region (2021-2026)
  5. 4.2.3 Global EGFR-TKI Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global EGFR-TKI Forecasted Market Size by Region
  7. 4.3.1 Global EGFR-TKI Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global EGFR-TKI Sales in Value by Region (2027-2032)
  9. 4.3.3 Global EGFR-TKI Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 EGFR-TKI by Application
  1. 5.1 EGFR-TKI Market by Application
  2. 5.1.1 Segment by Application
  3. 5.1.2 Hospital and Clinic
  4. 5.1.3 Retail Pharmacies
  5. 5.1.4 Other
  6. 5.2 Global EGFR-TKI Market Size by Application
  7. 5.2.1 Global EGFR-TKI Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global EGFR-TKI Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global EGFR-TKI Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America EGFR-TKI Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe EGFR-TKI Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific EGFR-TKI Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America EGFR-TKI Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa EGFR-TKI Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 ArriVent Biopharma
  2. 6.1.1 ArriVent Biopharma Company Information
  3. 6.1.2 ArriVent Biopharma Business Overview
  4. 6.1.3 ArriVent Biopharma EGFR-TKI Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 ArriVent Biopharma EGFR-TKI Product Portfolio
  6. 6.1.5 ArriVent Biopharma Recent Developments
  7. 6.2 AstraZeneca
  8. 6.2.1 AstraZeneca Company Information
  9. 6.2.2 AstraZeneca Business Overview
  10. 6.2.3 AstraZeneca EGFR-TKI Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 AstraZeneca EGFR-TKI Product Portfolio
  12. 6.2.5 AstraZeneca Recent Developments
  13. 6.3 Beacon Pharma
  14. 6.3.1 Beacon Pharma Company Information
  15. 6.3.2 Beacon Pharma Business Overview
  16. 6.3.3 Beacon Pharma EGFR-TKI Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Beacon Pharma EGFR-TKI Product Portfolio
  18. 6.3.5 Beacon Pharma Recent Developments
  19. 6.4 Boehringer Ingelheim Pharmaceuticals
  20. 6.4.1 Boehringer Ingelheim Pharmaceuticals Company Information
  21. 6.4.2 Boehringer Ingelheim Pharmaceuticals Business Overview
  22. 6.4.3 Boehringer Ingelheim Pharmaceuticals EGFR-TKI Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Boehringer Ingelheim Pharmaceuticals EGFR-TKI Product Portfolio
  24. 6.4.5 Boehringer Ingelheim Pharmaceuticals Recent Developments
  25. 6.5 Cipla
  26. 6.5.1 Cipla Company Information
  27. 6.5.2 Cipla Business Overview
  28. 6.5.3 Cipla EGFR-TKI Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Cipla EGFR-TKI Product Portfolio
  30. 6.5.5 Cipla Recent Developments
  31. 6.6 Drug International
  32. 6.6.1 Drug International Company Information
  33. 6.6.2 Drug International Business Overview
  34. 6.6.3 Drug International EGFR-TKI Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Drug International EGFR-TKI Product Portfolio
  36. 6.6.5 Drug International Recent Developments
  37. 6.7 Glenmark Pharmaceuticals
  38. 6.7.1 Glenmark Pharmaceuticals Company Information
  39. 6.7.2 Glenmark Pharmaceuticals Business Overview
  40. 6.7.3 Glenmark Pharmaceuticals EGFR-TKI Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Glenmark Pharmaceuticals EGFR-TKI Product Portfolio
  42. 6.7.5 Glenmark Pharmaceuticals Recent Developments
  43. 6.8 Hanmi Pharmaceutical
  44. 6.8.1 Hanmi Pharmaceutical Company Information
  45. 6.8.2 Hanmi Pharmaceutical Business Overview
  46. 6.8.3 Hanmi Pharmaceutical EGFR-TKI Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Hanmi Pharmaceutical EGFR-TKI Product Portfolio
  48. 6.8.5 Hanmi Pharmaceutical Recent Developments
  49. 6.9 Johnson & Johnson
  50. 6.9.1 Johnson & Johnson Company Information
  51. 6.9.2 Johnson & Johnson Business Overview
  52. 6.9.3 Johnson & Johnson EGFR-TKI Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Johnson & Johnson EGFR-TKI Product Portfolio
  54. 6.9.5 Johnson & Johnson Recent Developments
  55. 6.10 Mylan
  56. 6.10.1 Mylan Company Information
  57. 6.10.2 Mylan Business Overview
  58. 6.10.3 Mylan EGFR-TKI Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Mylan EGFR-TKI Product Portfolio
  60. 6.10.5 Mylan Recent Developments
  61. 6.11 Pfizer
  62. 6.11.1 Pfizer Company Information
  63. 6.11.2 Pfizer Business Overview
  64. 6.11.3 Pfizer EGFR-TKI Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Pfizer EGFR-TKI Product Portfolio
  66. 6.11.5 Pfizer Recent Developments
  67. 6.12 Roche
  68. 6.12.1 Roche Company Information
  69. 6.12.2 Roche Business Overview
  70. 6.12.3 Roche EGFR-TKI Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Roche EGFR-TKI Product Portfolio
  72. 6.12.5 Roche Recent Developments
  73. 6.13 Teva
  74. 6.13.1 Teva Company Information
  75. 6.13.2 Teva Business Overview
  76. 6.13.3 Teva EGFR-TKI Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Teva EGFR-TKI Product Portfolio
  78. 6.13.5 Teva Recent Developments
  79. 6.14 Yuhan Corporation
  80. 6.14.1 Yuhan Corporation Company Information
  81. 6.14.2 Yuhan Corporation Business Overview
  82. 6.14.3 Yuhan Corporation EGFR-TKI Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Yuhan Corporation EGFR-TKI Product Portfolio
  84. 6.14.5 Yuhan Corporation Recent Developments
  85. 6.15 Betta Pharma
  86. 6.15.1 Betta Pharma Company Information
  87. 6.15.2 Betta Pharma Business Overview
  88. 6.15.3 Betta Pharma EGFR-TKI Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Betta Pharma EGFR-TKI Product Portfolio
  90. 6.15.5 Betta Pharma Recent Developments
  91. 6.16 Chengdu Brilliant Pharmaceuticals
  92. 6.16.1 Chengdu Brilliant Pharmaceuticals Company Information
  93. 6.16.2 Chengdu Brilliant Pharmaceuticals Business Overview
  94. 6.16.3 Chengdu Brilliant Pharmaceuticals EGFR-TKI Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Chengdu Brilliant Pharmaceuticals EGFR-TKI Product Portfolio
  96. 6.16.5 Chengdu Brilliant Pharmaceuticals Recent Developments
  97. 6.17 Hansoh Pharma
  98. 6.17.1 Hansoh Pharma Company Information
  99. 6.17.2 Hansoh Pharma Business Overview
  100. 6.17.3 Hansoh Pharma EGFR-TKI Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Hansoh Pharma EGFR-TKI Product Portfolio
  102. 6.17.5 Hansoh Pharma Recent Developments
  103. 6.18 Shanghai Allist Pharmaceuticals
  104. 6.18.1 Shanghai Allist Pharmaceuticals Company Information
  105. 6.18.2 Shanghai Allist Pharmaceuticals Business Overview
  106. 6.18.3 Shanghai Allist Pharmaceuticals EGFR-TKI Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Shanghai Allist Pharmaceuticals EGFR-TKI Product Portfolio
  108. 6.18.5 Shanghai Allist Pharmaceuticals Recent Developments
  109. 6.19 Wanbang Biopharmaceuticals
  110. 6.19.1 Wanbang Biopharmaceuticals Company Information
  111. 6.19.2 Wanbang Biopharmaceuticals Business Overview
  112. 6.19.3 Wanbang Biopharmaceuticals EGFR-TKI Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Wanbang Biopharmaceuticals EGFR-TKI Product Portfolio
  114. 6.19.5 Wanbang Biopharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America EGFR-TKI Sales by Country
  2. 7.1.1 North America EGFR-TKI Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America EGFR-TKI Sales by Country (2021-2026)
  4. 7.1.3 North America EGFR-TKI Sales Forecast by Country (2027-2032)
  5. 7.2 North America EGFR-TKI Market Size by Country
  6. 7.2.1 North America EGFR-TKI Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America EGFR-TKI Market Size by Country (2021-2026)
  8. 7.2.3 North America EGFR-TKI Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe EGFR-TKI Sales by Country
  2. 8.1.1 Europe EGFR-TKI Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe EGFR-TKI Sales by Country (2021-2026)
  4. 8.1.3 Europe EGFR-TKI Sales Forecast by Country (2027-2032)
  5. 8.2 Europe EGFR-TKI Market Size by Country
  6. 8.2.1 Europe EGFR-TKI Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe EGFR-TKI Market Size by Country (2021-2026)
  8. 8.2.3 Europe EGFR-TKI Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific EGFR-TKI Sales by Country
  2. 9.1.1 Asia-Pacific EGFR-TKI Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific EGFR-TKI Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific EGFR-TKI Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific EGFR-TKI Market Size by Country
  6. 9.2.1 Asia-Pacific EGFR-TKI Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific EGFR-TKI Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific EGFR-TKI Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America EGFR-TKI Sales by Country
  2. 10.1.1 South America EGFR-TKI Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America EGFR-TKI Sales by Country (2021-2026)
  4. 10.1.3 South America EGFR-TKI Sales Forecast by Country (2027-2032)
  5. 10.2 South America EGFR-TKI Market Size by Country
  6. 10.2.1 South America EGFR-TKI Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America EGFR-TKI Market Size by Country (2021-2026)
  8. 10.2.3 South America EGFR-TKI Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa EGFR-TKI Sales by Country
  2. 11.1.1 Middle East and Africa EGFR-TKI Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa EGFR-TKI Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa EGFR-TKI Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa EGFR-TKI Market Size by Country
  6. 11.2.1 Middle East and Africa EGFR-TKI Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa EGFR-TKI Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa EGFR-TKI Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 EGFR-TKI Value Chain Analysis
  2. 12.1.1 EGFR-TKI Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 EGFR-TKI Production Mode & Process
  7. 12.2 EGFR-TKI Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 EGFR-TKI Distributors
  10. 12.2.3 EGFR-TKI Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst